Navigation Links
Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting

adverse events commonly associated with the use of methylphenidate.

About SPD465 (triple-bead mixed amphetamine salts):

SPD465 is currently under review with the U.S. Food and Drug Administration (FDA) for the treatment of ADHD in adults. SPD465, a single entity, mixed amphetamine salt formulation was studied to determine if it provides symptom control for up to 16 hours in adults with ADHD. The most commonly reported treatment-emergent adverse events were decreased appetite, insomnia, dry mouth, headache, upper abdominal pain and anorexia.

About SPD503 (guanfacine HCl extended release):

SPD503 is currently under review with FDA for the treatment of ADHD in children aged 6 to 17 years. SPD503 is a once-daily formulation of the selective alpha-2A-adrenoceptor agonist guanfacine and was studied to determine if it provided control of ADHD symptoms throughout the day in children aged 6 to 17 years. The most commonly reported treatment-emergent adverse events were headache, somnolence, fatigue, upper abdominal pain and sedation.

About ADHD

Approximately 7.8 percent of all school-age children, or about 4.4 million U.S. children aged 4 to 17 years, have been diagnosed with ADHD at some point in their lives, according to the CDC. ADHD is one of the most common psychiatric disorders in children and adolescents. The disorder is also estimated to affect approximately 9.8 million adults across the U.S. based on a retrospective survey of adults aged 18 to 34, projected to the full U.S. adult population. ADHD is a neurobiological psychiatric disorder that manifests as a persistent pattern of inattention and/or hyperactivity- impulsivity that is more frequent and severe than is typically observed in individuals at a comparable level of development. To be properly diagnosed with ADHD, a child needs to demonstrate at least six of nine symptoms of inattention; and/or at least six of nine symptoms of hyperactivity/impulsivity; the onset of wh
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference

Post Your Comments:
(Date:11/6/2009)..., DETROIT, Nov. 6 Car... CPD ) has launched ketorolac tromethamine ophthal... the US Food and Drug Administration (FDA) for Sun...for generic Acular® opthalmic solution on the...gth of ketorolac is therapeutically equivalent to ...
(Date:11/5/2009)..., SAN DIEGO, Nov. 5 Althea Tec... and manufacturing services for biopharmaceutical ...ulation Development to the company,s platform of s...nted Dr. James Matsuura, Director of Formulation D... of formulation and analytical scientists, along w...
(Date:11/5/2009)..., FULLERTON, Calif., Nov. 5 Ren...associate professor of dermatology at the Universi... patients are experiencing tremendous results with...approved for skin tightening and contouring, featu...edure efficacy and improves patient comfort. ,...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2Artificial liver may extend lives 47650 1Artificial liver may extend lives 47650 2Researchers Suggest That Oxidative Stress is Strongly Evident in the In Utero Environment of the Fetus With Down Syndrome 47646 1Researchers Suggest That Oxidative Stress is Strongly Evident in the In Utero Environment of the Fetus With Down Syndrome 47646 2Study 3A Benefit to women not enough to sway men to get HPV vaccine 47643 1Study 3A Benefit to women not enough to sway men to get HPV vaccine 47643 2Study 3A Benefit to women not enough to sway men to get HPV vaccine 47643 3
... Tanespimycin TIME Registration Program to Begin T.../PRNewswire-FirstCall/ -- Kosan,Biosciences Incorp... 1b clinical trial of its lead Hsp90 inhibitor, ta...b (Velcade(R)), showing a,high degree of antitumor...le myeloma who had previously progressed following...
... CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 4, 2007 - ...IPI) announced today that the,company will present... 54th annual meeting of the Society of Nuclear Med...include data on Azedra(TM),(Ultratrace (131)I-MIBG...rapeutic candidate for the treatment of malignant,...
Other Medicine Technology:Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 2Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 3Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 4Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 5Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing,Promising Antitumor Activity in Multiple Myeloma at ASCO 6Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 2Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 3Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting 4
(Date:11/7/2009)...across the U.S. , , SATURDAY, Nov. 7 (Heal...r colleges do it regularly (and, it,s not sex). , ...e alcoholic drinks at a sitting. , "People have a ...ny Hwang, associate dean of students and director ... on Long Island, N.Y. In fact, she said, heavy dri...
(Date:11/7/2009)...omic climate, many Americans are monitoring their ... what that they consider to be absolutely essentia...ves that it’s very important for overweight ...prove their health, and he is trying to make weigh...h economy by offering reasonable prices and multip...
(Date:11/7/2009)...om Greensations fights pain and increases circulat...ermaFeet targets foot pain and soreness with a soo...nut, Goldenseal, Vitamin C and Alpha Lipoic Acid. ...B) November 7, 2009 -- A new foot spray from Green... the power of hot peppers and caffeine. The main p...
(Date:11/6/2009)...gia graduate was featured in a local news show abo...e special report focused on the growing problem of...ndrew shared his near death experience and his bel...on drug abuse. ,, "I woke up, blinked once and the...n top of me giving me CPR. I saw tears streaming d...
(Date:11/6/2009)...th pledge-breaking tax hikes ,, WASHINGTON, Nov....for Tax Reform: ,, By formally endorsing the H... effectively announced that the central promise of...ign, Obama made a "firm pledge" not to raise " an...50,000 per year: ,, "I can make a firm pledge. U...
Breaking Medicine News(10 mins):Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3Health News:Hot Peppers and Caffeine Relieve Painful Feet, Toe Fungus and Foot Odor 2Health News:Narconon Drug Rehab of Georgia Graduate Featured on Local News 2Health News:ATR: Obama Lied, His Tax Pledge Died 2Health News:ATR: Obama Lied, His Tax Pledge Died 3
...es LLC, formerly Mealey,s Conferences, is hosting ...cs in Pharmaceutical Litigation 2009" on Feb. 23 a... on the following products: Byetta, Trasvaginal S...on case filings; the alleged injuries; medical evi...
... on several factors, , , TUESDAY, Feb. 3 (...dely among people who undergo computed tomography ...blished in the Feb. 4 issue of the Journal of the...ing radiation. That recommendation came in an advi...
...schle withdrew his name for consideration as a nom...rtment (HHS). From the beginning Senator Daschle ...ident Obama for a government takeover of our natio...ogo: http://www.newscom.com/cgi-bin/prnh/2008093...
...oup EVP Will Strengthen Firm,s Credentials in Busi...y , Orlando, FL (PRWEB) F...day that it has selected Steven G. Auerbach for th...ompany,s sites in Florida, North Carolina and Indi...
... Trust,Incorporated (NYSE: HR ) today announced ...ed December 31, 2008. This dividend, in the amoun... to shareholders of record on February 20,2009. , ...associated primarily with the delivery of outpatie...
...part in regular physical activity have a better qu...y issue of the journal Cancer Epidemiology Biomar...nts who are more physically active report better m...both mentally and physically, from simple moderate...
Other Medicine News:Health News:Pharmaceutical Litigation Teleconference Feb. 23 2Health News:Radiation From CT Scans Not Always the Same 2Health News:Radiation From CT Scans Not Always the Same 3Health News:Connextions Inc. Hires Steven G. Auerbach as President 2Health News:Connextions Inc. Hires Steven G. Auerbach as President 3Health News:Regular physical activity linked to better quality of life in early-stage lung cancer survivors 2
Bicycle Ergometer
...be the best stress treadmill in the industry. Trac...le than any competitor, while centering the design.... It is self-calibrating, virtually maintenance-fr...eck, incredibly smooth belt operation and an easy-...
...ECG Systems offer clinical features to meet any te...unctionality for paperless storage. Flexible, affo... Exercise ECG software turns any computer into a p...o connect with leading EMR systems, the family of ...
Q-Stress Cardiac Stress System
Medicine Products: